This story was first published in digitalhealth.net
NICE approves three quarters of the Cancer Drugs Fund
The National Institute for Health and Care Excellence (NICE) has approved three quarters of the CDF, meaning that patients are getting faster access to cancer drugs.
NICE has recommended liver cancer drug, sorafenib, made by Bayer to be routinely available for some patients on the NHS.
Sorafenib, also known as Nexavar, is one of the 24 drugs NICE was asked to appraise from the Cancer Drugs Fund (CDF), and all have been approved so far for routine NHS use.
Its positive recommendation means that NICE is now three quarters of the way through the CDF with 18 drugs approved.
Companies like Bayer have provided discounts and additional evidence meaning the drugs can be considered as cost effective for routine NHS use.
Sorafenib is recommended for some people with liver cancer that has progressed. It is predicted that the drug extends life by up to three months.
Carole Longson, director of the NICE centre for health technology evaluation, said: “Working closely with companies and NHS England, we are delivering our promise to give people fast access to the most cost-effective cancer drugs.”
“More cancer drugs than ever are being recommended for routine use because companies are working hard to provide cost-effective solutions. We are also applying flexibility in cases where drugs show promise, meaning people get access through the new CDF while further data is generated.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
